|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 213/74 | |
| C07D 401/06 | |||
| C07D 401/14 | |||
| C07D 413/14 | |||
| C07D 401/04 | |||
| C07D 413/04 | |||
| C07D 417/04 | |||
| C07D 417/14 | |||
| A61K 31/4427 | |||
| A61P 9/00 |
| (11) | Patento numeris | 3526198 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17788068.9 |
| Europos patento paraiškos padavimo data | 2017-10-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/056265 |
| Data | 2017-10-12 |
| (87) | Numeris | WO 2018/071622 |
| Data | 2018-04-19 |
| (30) | Numeris | Data | Šalis |
| 201662408272 P | 2016-10-14 | US |
| (72) |
RICHTER, Jeremy M., US
BATES, J. Alex, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS |
| 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS |